How investors killed AstraZeneca’s $400bn megadeal

FT · August 11, 2026

Generating summary...

Enjoying OptionsWhisper?

Built by a solo developer. Free and curated for you.

Rate on the App Store Upgrade to Pro

Original at FT → Search for more →

More from the feed

WSJ A Herbal Product Sold at Gas Stations Is Being Blamed for an Addiction Crisis just now

BLOOMBERG Chobani Cuts Annual Earnings Forecast on Rising Material Costs 1h ago

BLOOMBERG CSN Gets Financial Relief as $1 Billion Debt Exchange Approved 1h ago

BLOOMBERG Russia’s Crude Oil Exports Tumble to Their Lowest Since May 1h ago

BLOOMBERG NYSE Parent ICE Kicks Off Bond Sale for MarketAxess Takeover 1h ago

OptionsWhisperThe market, whispered.›